http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36724992
Outgoing Links
| Predicate | Object |
|---|---|
| contentType | Journal Article|Review |
| issn | 0920-1211 |
| pageRange | 107286- |
| startingPage | 107286 |
| bibliographicCitation | Fitzgerald PJ. Neural hyperexcitability in Angelman syndrome: Genetic factors and pharmacologic treatment approaches. Epilepsy Res. 2024 Feb;200():107286. doi: 10.1016/j.eplepsyres.2024.107286. PMID: 38217951. |
| creator | http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a297f9c745c54f5c047c8cd8e2417e47 |
| date | 202402 |
| identifier | https://pubmed.ncbi.nlm.nih.gov/38217951 https://doi.org/10.1016/j.eplepsyres.2024.107286 |
| isPartOf | http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587 https://portal.issn.org/resource/ISSN/0920-1211 |
| language | English |
| source | https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
| title | Neural hyperexcitability in Angelman syndrome: Genetic factors and pharmacologic treatment approaches |
| discusses | http://id.nlm.nih.gov/mesh/M0001382 http://id.nlm.nih.gov/mesh/M0022501 |
Total number of triples: 17.